Cronos GroupCRON
About: Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.
Employees: 459
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
46% more call options, than puts
Call options by funds: $5.58M | Put options by funds: $3.81M
0.2% more ownership
Funds ownership: 11.35% [Q4 2024] → 11.55% (+0.2%) [Q1 2025]
0% more funds holding in top 10
Funds holding in top 10: 1 [Q4 2024] → 1 (+0) [Q1 2025]
6% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 36
9% less capital invested
Capital invested by funds: $87.6M [Q4 2024] → $80M (-$7.61M) [Q1 2025]
11% less funds holding
Funds holding: 184 [Q4 2024] → 164 (-20) [Q1 2025]
48% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 31
Research analyst outlook
We haven’t received any recent analyst ratings for CRON.
Financial journalist opinion
Based on 6 articles about CRON published over the past 30 days









